Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12201655
Antimicrobial therapy
granted -
US 12201598
Immunoregulatory microparticles for modulating inflammatory arthritides
granted -
US 12201453
Microneedle fabrication and device implantation
granted -
US 12195620
Controlled entrapment and release of molecular cargo
granted -
US 12195766
Tumor-selective E1a and E1b mutants
granted -
US 12195540
Antibodies that bind integrin αvβ8 and uses thereof
granted -
US 12186342
Autologous irradiated whole cell tumor vaccines lentivirally engineered to express CD80, IL-15 and IL-15 receptor alpha
granted -
US 12187694
SLC26A3 inhibitors and use thereof
granted -
US 12187762
Dithiolsaccharide mucolytic agents and uses thereof
granted -
US 12186367
Isoform Nell-1 peptide
granted -
US 12188949
Noninvasive method to quantify kidney function and functional decline
granted -
US 12186368
Compositions and methods for treatment of protease mediated disease
granted -
US 12187848
Compositions and methods for cellular delivery
granted -
US 12187777
Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof
granted -
US 12187992
Method and device for early cancer screening
granted -
US 12186369
Gene therapy strategy to restore electrical and cardiac function, and cardiac structure, in arrhythmogenic right ventricular cardiomyopathy
granted -
US 12180503
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 12180084
Cerium (III) carbonate formulations
granted -
US 12180504
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 12178887
NIR-conjugated tumor-specific antibodies and uses thereof
granted -
US 12171884
Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
granted -
US 12173029
Antiviral prodrugs, pharmaceutical formulations, and methods
granted -
US 12171786
Use of mesenchymal stem cells for the treatment of inflammation
granted -
US 12171877
Materials and methods for delivering compositions to selected tissues
granted